There is no doubt that the current financing landscape and resultant company restructures or closures are having a significant impact on those individuals involved. It is not just financing, or lack of, that causes such staff turnover, of course. Business growth can lead to new skills and capacities being prioritised; deal-making such as M&A can equally force change, as indeed can personal circumstances. The reasons a life science company employee can find themselves between jobs can be varied and for negative impacts as well as positive choices. Whatever the reason, staying involved in…
by Tony Jones, CEO, One Nucleus
Being Asked to Do More With Less
The cascading challenge before the sector currently with respect to both companies and individuals working in it could be summarised as:
A lack of investment capital making its way into life science R&D companies
Life science R&D companies having to reduce cash burn to prolong financial survival
A shift in focus to later-stage programmes, making earlier research programmes vulnerable
Staff redundancies and highly valuable skills sitting unused
Personal impacts of job losses being felt and the wellbeing deficiencies of…
By Monalisa Breazu, Learning & Development Administrator
Earlier this month, we hosted two lively roundtable discussions with One Nucleus members. The conversations spanned everything from the value of networking to how we can better support professionals at different career stages to rethinking what “training” really means in today’s life sciences sector. Below are some of the key takeaways …
The Power of Networking
Networking remains a cornerstone of professional growth, yet it is often undervalued or misunderstood. Participants highlighted the importance of reframing networking as a…
By Philippa Clark, Director of Business Development, One Nucleus
In life sciences, we naturally celebrate the power of collaboration. Innovation breakthroughs rarely happen in isolation; they are the result of expertise, ideas, and resources coming together in ways that no single organisation could achieve alone. However, when it comes to networking, the value is too often judged through the narrow lens of short-term outcomes.
Throughout my career, I’ve often been asked the same question after attending an event: “What was the return on investment?”, “How many leads did you get?”, “How…
R&D procurement might seem straightforward, but behind the scenes, small mistakes can cause big headaches for labs. Mismanaged orders, unexpected product delays, and budget overruns can derail even the best-laid research plans.
The good news? With a little insight and a few process tweaks, many common pitfalls are easy to avoid. Let’s take a look at the top lab procurement mistakes and how you can sidestep them to keep your research moving forward without disruption.
Common lab procurement mistakes (and how to fix them)
Mistake
Quick Fix
Pro Tip
🔒 Relying on a small supplier…
In an article in Pharmexec, May 2024, the author identified seven essential attributes that investors look for before investing in Life Sciences. Among the seven was a “proven management team”. And this was described as “paramount”.
I remembered seeing something similar in Excedr’s online piece on ‘Top VC Firms for Biotech in 2024: Supporting Innovation & Growth’, where they cited “fostering a strong management team” as “the biggest factor that smart investors consider”.
“But what does this actually mean?” and “What capabilities are investors wanting to see?”, I remember…
by Alicia Gailliez, Business Development Manager, One Nucleus
This year’s ON Helix conference at the Babraham Research Campus brought together biotech innovators, service providers, pharma leaders, investors, and academics in an interactive atmosphere to explore cutting-edge developments in tools, therapeutics, devices, and ecosystems that are shaping the future of translational research.
More than just a translational research conference, ON Helix creates a space to address the most pressing scientific challenges facing our community and crucially to explore solutions that accelerate the…
There are times when it can feel like a small world when chance meetings and connections are encountered. On the flip side, when a company is seeking the right investor, collaborator or client, then the world can seem awfully big without some guidance of where to look.
Biotech and Pharma Investment Raised Between June 2020 and June 2025
With the global deal count and investment raised remaining somewhat challenged, then perhaps the dealmaker’s world feels smaller but less connected. The UK, accounting for around approximately 7% of total investment raised and deal…
By Monalisa Breazu, Learning & Development Administrator
In today's competitive and challenging life sciences landscape, your people truly are your most valuable asset when convincing investors, partners, and customers to believe you can execute plans effectively. Competition for the most talented, skilled professionals in all roles is always intense, with the options open to companies being (i) buy it in ready-trained; (ii) borrow it via outsourcing; or (iii) grow your own. Growing your own can take time and budget when resources are stretched like now, but it can be the most effective…
by Tony Jones, CEO, One Nucleus
Photography by www.SimonCallaghanPhotography.com
Posing the question to myself of whether networking has impacted my career and professional life, then I feel the short answer is an absolute yes. Given I am CEO at an organisation that, among other forms of support, delivers networking opportunities for employees of our member organisations, that may not be too surprising, you may think. Let me explain why I think networking has been key to my career journey, and perhaps it will then also explain why I’ve ended up in the role I am in – a logic I had not…